Overview

Relative Bioavailability and Food Effect Study

Status:
Withdrawn
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Initial studies have used a powder in capsule formulation of PH797804. In future studies an immediate release tablet will be used. The purpose of this study is to compare blood levels of PH797804 following an oral dose of the powder in capsule formulation and the tablet formulation. In addition the effect of food blood levels of PH797804 will be investigated
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer